Source:http://linkedlifedata.com/resource/pubmed/id/20535127
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
2010-9-15
|
pubmed:abstractText |
The active metabolite of vitamin D, 1,25-dihydroxyvitamin D(3) (1,25(OH)(2)D(3)), and a series of 2-methylene-19-nor analogs of 1,25(OH)(2)D(3) were evaluated for their ability to reduce the size of utricles (comedolytic activity) in a rhino mouse model of acne. All analogs tested, as well as the native hormone, increased the skin epidermal thickness. In contrast, only a subset of analogs that lacked a full side chain and 25-hydroxyl group were found to possess comedolytic activity. A reduction in comedone area could be achieved without adversely affecting serum calcium levels. Although all compounds that contained a side chain ranging from 2 to 5 carbons in length had similar potency as comedolytic agents, increasing the length of the side chain resulted in a progressive increase in calcemic liability. Dose-response studies of the comedolytic analogs showed that an increase in epidermal thickness was achieved at a lower dose than that needed to induce comedolysis. Thus, we have identified a unique subset of vitamin D analogs that produce comedolysis in the absence of hypercalcemia. Further, the activity of vitamin D analogs in causing epidermal hyperproliferation has been distinguished from that resulting in a reduction in utricle size.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/19-nor-1,24,25-trihydroxyvitamin D2,
http://linkedlifedata.com/resource/pubmed/chemical/2-methylene-19-nor-(20S)-1...,
http://linkedlifedata.com/resource/pubmed/chemical/2-methylene-19-nor-(20S)-1alpha,25-d...,
http://linkedlifedata.com/resource/pubmed/chemical/Calcitriol,
http://linkedlifedata.com/resource/pubmed/chemical/Calcium,
http://linkedlifedata.com/resource/pubmed/chemical/Dihydroxycholecalciferols,
http://linkedlifedata.com/resource/pubmed/chemical/Ergocalciferols
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1523-1747
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
130
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2359-67
|
pubmed:meshHeading |
pubmed-meshheading:20535127-Acne Vulgaris,
pubmed-meshheading:20535127-Animals,
pubmed-meshheading:20535127-Calcitriol,
pubmed-meshheading:20535127-Calcium,
pubmed-meshheading:20535127-Cell Differentiation,
pubmed-meshheading:20535127-Dihydroxycholecalciferols,
pubmed-meshheading:20535127-Disease Models, Animal,
pubmed-meshheading:20535127-Dose-Response Relationship, Drug,
pubmed-meshheading:20535127-Epidermis,
pubmed-meshheading:20535127-Ergocalciferols,
pubmed-meshheading:20535127-Female,
pubmed-meshheading:20535127-Hyperkeratosis, Epidermolytic,
pubmed-meshheading:20535127-Isomerism,
pubmed-meshheading:20535127-Male,
pubmed-meshheading:20535127-Mice,
pubmed-meshheading:20535127-Mice, Hairless,
pubmed-meshheading:20535127-Mice, Mutant Strains
|
pubmed:year |
2010
|
pubmed:articleTitle |
Identification of a unique subset of 2-methylene-19-nor analogs of vitamin D with comedolytic activity in the rhino mouse.
|
pubmed:affiliation |
Pharmaceutical Sciences Division, School of Pharmacy, University of Wisconsin-Madison, Madison, Wisconsin, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|